乳腺活检定位夹选择:对影像流程、随访与成本的影响
本文综述乳腺活检定位夹从单一金属夹到多材料装置的发展历程及其在乳腺诊疗全程中的作用。文章总结现代定位夹可标记活检部位、支持多模态影像对照、指导手术与放疗,长期安全性良好并具成本效益。同时讨论定位夹移位、过敏反应、超声可见度差等现存挑战及最新技术改进与操作最佳实践。
要点
- 根据患者个体因素选择合适的定位夹类型,金属过敏者应考虑非金属替代品。
- 置入定位夹后注意评估有无移位,尤其是后续影像与活检部位不符时。
- 超声复查时可利用多普勒「闪烁」伪影提高定位夹的可见性。
核心结论
- 现代乳腺活检定位夹在活检部位标记、多模态影像对照、手术与放疗靶区引导及跨机构诊疗连续性中发挥关键作用。
- 定位夹长期安全性良好,不良事件极少,通过提高手术精度和降低再次切除率体现出显著的成本效益。
- 现存挑战包括定位夹移位、金属或包埋材料过敏反应以及超声下可见度受限,最新技术已在设计中予以改进。
研究设计与样本
- 本文为叙述性综述,回顾了乳腺活检定位夹从1960年代MD Anderson癌症中心起始至1995年MicroMark获FDA批准、1999年应用于乳腺患者及2003年成为标准操作的演进过程。
- 文中汇总了长期研究证据、当代技术进展与现行最佳实践建议,未报告纳入文献的检索策略或具体数量。
诊断标准与关键数值
- 定位夹的最佳实践包括:选择最佳置入时机、根据患者特异性因素选择定位夹类型、预防移位技术以及利用多普勒超声「闪烁」伪影增强超声可见度。
临床应用与阅片要点
- 报告中应关注定位夹有无移位,当后续影像定位与预期活检部位不一致时需警惕移位的可能。
- 超声复查时可主动使用多普勒「闪烁」伪影帮助识别超声下可见度差的定位夹。
- 对有金属过敏史的患者,选择定位夹时应考虑非金属替代材料。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Breast biopsy markers have evolved from simple metallic markers to sophisticated multimaterial devices that serve critical purposes throughout the breast cancer care continuum. This evolution began at The University of Texas MD Anderson Cancer Center in the 1960s for gynecologic and head and neck tumors. After the MicroMark (Biopsys) clip was approved by the U.S. Food and Drug Administration in 1995, markers were subsequently adapted for patients with breast cancer in 1999. By 2003, markers had become the standard of care. Modern markers serve multiple clinical functions: marking biopsy sites, facilitating cross-modality imaging correlation, guiding surgical planning and radiation therapy targeting, and ensuring continuity of care across health care facilities. Long-term studies demonstrate excellent safety profiles with minimal adverse events and significant cost-effectiveness through improved surgical precision and reduced re-excision rates. Despite the widespread adoption of these markers, contemporary challenges persist, including marker migration, allergic reactions to metallic components or embedding materials, and visibility limitations on US images. However, recent technological advances address these concerns through improved marker designs, nonmetallic alternatives, and innovative detection methods. Current best practices emphasize optimal placement timing, appropriate marker selection based on patient-specific factors, migration prevention techniques, and use of Doppler US "twinkling" artifacts for enhanced US visualization. © The Author(s) 2026. Published by the Radiological Society of North America under a CC BY 4.0 license. Supplemental material is available for this article.
引用
- Moseley, Adrada, Arribas, et al. Selection of Breast Biopsy Markers: Effect on Breast Imaging Procedures, Follow-up, and Costs. Radiographics. 2026. PMID: 42594023. doi:10.1148/rg.250151
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。